Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 176

Similar articles for PubMed (Select 21501431)

1.
2.

Protective efficacy of interventions for preventing malaria mortality in children in Plasmodium falciparum endemic areas.

Eisele TP, Larsen D, Steketee RW.

Int J Epidemiol. 2010 Apr;39 Suppl 1:i88-101. doi: 10.1093/ije/dyq026. Review.

3.

Artemisinin derivatives versus quinine in treating severe malaria in children: a systematic review.

Praygod G, de Frey A, Eisenhut M.

Malar J. 2008 Oct 17;7:210. doi: 10.1186/1475-2875-7-210. Review.

4.

Treating uncomplicated malaria in children: comparing artemisinin-based combination therapies.

Yeka A, Harris JC.

Curr Opin Pediatr. 2010 Dec;22(6):798-803. doi: 10.1097/MOP.0b013e32833fac44. Review.

5.

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.

Dondorp AM, Fanello CI, Hendriksen IC, Gomes E, Seni A, Chhaganlal KD, Bojang K, Olaosebikan R, Anunobi N, Maitland K, Kivaya E, Agbenyega T, Nguah SB, Evans J, Gesase S, Kahabuka C, Mtove G, Nadjm B, Deen J, Mwanga-Amumpaire J, Nansumba M, Karema C, Umulisa N, Uwimana A, Mokuolu OA, Adedoyin OT, Johnson WB, Tshefu AK, Onyamboko MA, Sakulthaew T, Ngum WP, Silamut K, Stepniewska K, Woodrow CJ, Bethell D, Wills B, Oneko M, Peto TE, von Seidlein L, Day NP, White NJ; AQUAMAT group.

Lancet. 2010 Nov 13;376(9753):1647-57. doi: 10.1016/S0140-6736(10)61924-1. Epub 2010 Nov 7. Erratum in: Lancet. 2011 Jan 8;377(9760):126.

6.

Randomized, multicentre assessment of the efficacy and safety of ASAQ--a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria.

Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, Faye B, Randrianasolo L, Ratsimbasoa A, Forlemu D, Moor VA, Traore A, Dicko Y, Dara N, Lameyre V, Diallo M, Djimde A, Same-Ekobo A, Gaye O.

Malar J. 2009 Jun 8;8:125. doi: 10.1186/1475-2875-8-125.

7.

Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial.

Ramharter M, Oyakhirome S, Klein Klouwenberg P, Adégnika AA, Agnandji ST, Missinou MA, Matsiégui PB, Mordmüller B, Borrmann S, Kun JF, Lell B, Krishna S, Graninger W, Issifou S, Kremsner PG.

Clin Infect Dis. 2005 Jun 15;40(12):1777-84. Epub 2005 May 3.

8.

A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy.

Manyando C, Kayentao K, D'Alessandro U, Okafor HU, Juma E, Hamed K.

Malar J. 2012 May 1;11:141. doi: 10.1186/1475-2875-11-141. Review.

9.

Artemisinin-based combination therapy for treating uncomplicated malaria.

Sinclair D, Zani B, Donegan S, Olliaro P, Garner P.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007483. doi: 10.1002/14651858.CD007483.pub2. Review.

PMID:
19588433
10.

Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?

Ogutu B, Tiono AB, Makanga M, Premji Z, Gbadoé AD, Ubben D, Marrast AC, Gaye O.

Malar J. 2010 Jan 22;9:30. doi: 10.1186/1475-2875-9-30.

11.

UK malaria treatment guidelines.

Lalloo DG, Shingadia D, Pasvol G, Chiodini PL, Whitty CJ, Beeching NJ, Hill DR, Warrell DA, Bannister BA; HPA Advisory Committee on Malaria Prevention in UK Travellers.

J Infect. 2007 Feb;54(2):111-21. Epub 2007 Jan 9.

PMID:
17215045
12.

Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.

Noedl H, Krudsood S, Chalermratana K, Silachamroon U, Leowattana W, Tangpukdee N, Looareesuwan S, Miller RS, Fukuda M, Jongsakul K, Sriwichai S, Rowan J, Bhattacharyya H, Ohrt C, Knirsch C.

Clin Infect Dis. 2006 Nov 15;43(10):1264-71. Epub 2006 Oct 12.

13.

Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: an appropriate public health policy?

Yeka A, Achan J, D'Alessandro U, Talisuna AO.

Lancet Infect Dis. 2009 Jul;9(7):448-52. doi: 10.1016/S1473-3099(09)70109-4. Review.

PMID:
19555904
14.

Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial.

Achan J, Tibenderana JK, Kyabayinze D, Wabwire Mangen F, Kamya MR, Dorsey G, D'Alessandro U, Rosenthal PJ, Talisuna AO.

BMJ. 2009 Jul 21;339:b2763. doi: 10.1136/bmj.b2763.

15.

Intravenous artesunate for severe malaria.

[No authors listed]

Prescrire Int. 2008 Aug;17(96):168-70.

PMID:
19492495
16.

Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review.

Visser BJ, Wieten RW, Kroon D, Nagel IM, Bélard S, van Vugt M, Grobusch MP.

Malar J. 2014 Nov 26;13:463. doi: 10.1186/1475-2875-13-463. Review.

17.

Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trial.

Tine RC, Faye B, Ndour CT, Ndiaye JL, Ndiaye M, Bassene C, Magnussen P, Bygbjerg IC, Sylla K, Ndour JD, Gaye O.

Malar J. 2011 Dec 13;10:358. doi: 10.1186/1475-2875-10-358.

18.

Comparison of artemisinin suppositories, intramuscular artesunate and intravenous quinine for the treatment of severe childhood malaria.

Cao XT, Bethell DB, Pham TP, Ta TT, Tran TN, Nguyen TT, Pham TT, Nguyen TT, Day NP, White NJ.

Trans R Soc Trop Med Hyg. 1997 May-Jun;91(3):335-42.

PMID:
9231212
19.

Artemisinin derivatives and malaria: useful, in combination with other antimalarials.

[No authors listed]

Prescrire Int. 2008 Aug;17(96):162-8.

PMID:
19492494
20.

Comparison of Lives Saved Tool model child mortality estimates against measured data from vector control studies in sub-Saharan Africa.

Larsen DA, Friberg IK, Eisele TP.

BMC Public Health. 2011 Apr 13;11 Suppl 3:S34. doi: 10.1186/1471-2458-11-S3-S34. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk